Bengaluru: India’s leading diagnostics and healthcare solutions provider, LifeCell has recently expanded its diagnostics footprints into key markets including Kolkata and Pune. The ICMR and NABL accredited testing centres are equipped to handle COVID as well as other rapid biochemical and advanced genetic tests. With an extensive experience of handling over 7,00,000 COVID samples to date, the company has also extended support to the State Governments of Tamil Nadu, Karnataka, Delhi and Haryana by processing over 8,000 samples per day, helping in effectively managing the ongoing pandemic.
Commenting on the development, Mr. Ishaan Khanna, CEO, LifeCell International said, “LifeCell as a comprehensive healthcare brand has always worked hand-in-hand with the medical fraternity and the Government to offer the best possible support. While we were one of the early entrants to offer COVID Testing in India, the second wave hit everyone hard and visibly, there was a need for a prompt response.
Therefore, to further bolster our support & commitment towards the fight against COVID-19, we leverage our expertise and scale our operations to increase the accessibility of our testing services. We have so far successfully tested 7.3 lakh samples and we aim to add more centres in future to support the growing need.”
LifeCell’s five testing centres are located strategically across India including Chennai, Manesar, Bangalore, Kolkata, and Pune. These are well equipped with round-the-clock testing and collection support along with a well-trained team of professionals, enabling LifeCell to offer seamless service to its customers with quick turnaround times and clinically-approved reports even in such difficult times.
Additionally, with an aim to ensure the best care during the recovery journey of COVID-19 patients, LifeCell has emerged as a key diagnostics provider for the black fungus, COVID allied, and spike protein antibody testing. In fact, LifeCell has also been instrumental in offering uninterrupted diagnostic services in prenatal health and newborn care segments including routine biochemical tests as well as prenatal and DNA-based advanced screening from the comfort of home during COVID-19.
With the recent expansion, LifeCell will continue to provide affordable and accessible healthcare to its customers to help expedite their diagnostic journey.
